BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18334708)

  • 1. Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis.
    Frank B; Wiestler M; Kropp S; Hemminki K; Spurdle AB; Sutter C; Wappenschmidt B; Chen X; Beesley J; Hopper JL; ; Meindl A; Kiechle M; Slanger T; Bugert P; Schmutzler RK; Bartram CR; Flesch-Janys D; Mutschelknauss E; Ashton K; Salazar R; Webb E; Hamann U; Brauch H; Justenhoven C; Ko YD; Brüning T; Silva Idos S; Johnson N; Pharoah PP; Dunning AM; Pooley KA; Chang-Claude J; Easton DF; Peto J; Houlston R; ; Chenevix-Trench G; Fletcher O; Burwinkel B
    J Natl Cancer Inst; 2008 Mar; 100(6):437-42. PubMed ID: 18334708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium.
    Milne RL; Lorenzo-Bermejo J; Burwinkel B; Malats N; Arias JI; Zamora MP; Benítez J; Humphreys MK; García-Closas M; Chanock SJ; Lissowska J; Sherman ME; Mannermaa A; Kataja V; Kosma VM; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Anton-Culver H; Ziogas A; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Irwanto AK; Kang D; Yoo KY; Noh DY; Couch FJ; Olson JE; Wang X; Fredericksen Z; Nordestgaard BG; Bojesen SE; Flyger H; Margolin S; Lindblom A; Fasching PA; Schulz-Wendtland R; Ekici AB; Beckmann MW; Wang-Gohrke S; Shen CY; Yu JC; Hsu HM; Wu PE; Giles GG; Severi G; Baglietto L; English DR; Cox A; Brock I; Elliott G; Reed MW; Beesley J; Chen X; Investigators K; ; Fletcher O; Gibson L; dos Santos Silva I; Peto J; Frank B; Heil J; Meindl A; Chang-Claude J; Hein R; Vrieling A; Flesch-Janys D; Southey MC; Smith L; Apicella C; Hopper JL; Dunning AM; Pooley KA; Pharoah PD; Hamann U; Pesch B; Ko YD; ; Easton DF; Chenevix-Trench G
    J Med Genet; 2011 Oct; 48(10):698-702. PubMed ID: 21931171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.
    Milne RL; Burwinkel B; Michailidou K; Arias-Perez JI; Zamora MP; Menéndez-Rodríguez P; Hardisson D; Mendiola M; González-Neira A; Pita G; Alonso MR; Dennis J; Wang Q; Bolla MK; Swerdlow A; Ashworth A; Orr N; Schoemaker M; Ko YD; Brauch H; Hamann U; ; Andrulis IL; Knight JA; Glendon G; Tchatchou S; ; ; Matsuo K; Ito H; Iwata H; Tajima K; Li J; Brand JS; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Lambrechts D; Peuteman G; Christiaens MR; Smeets A; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Hartman M; Hui M; Yen Lim W; Wan Chan C; Marme F; Yang R; Bugert P; Lindblom A; Margolin S; García-Closas M; Chanock SJ; Lissowska J; Figueroa JD; Bojesen SE; Nordestgaard BG; Flyger H; Hooning MJ; Kriege M; van den Ouweland AM; Koppert LB; Fletcher O; Johnson N; dos-Santos-Silva I; Peto J; Zheng W; Deming-Halverson S; Shrubsole MJ; Long J; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Cox A; Cross SS; Reed MW; Schmidt MK; Broeks A; Cornelissen S; Braaf L; Kang D; Choi JY; Park SK; Noh DY; Simard J; Dumont M; Goldberg MS; Labrèche F; Fasching PA; Hein A; Ekici AB; Beckmann MW; Radice P; Peterlongo P; Azzollini J; Barile M; Sawyer E; Tomlinson I; Kerin M; Miller N; Hopper JL; Schmidt DF; Makalic E; Southey MC; Hwang Teo S; Har Yip C; Sivanandan K; Tay WT; Shen CY; Hsiung CN; Yu JC; Hou MF; Guénel P; Truong T; Sanchez M; Mulot C; Blot W; Cai Q; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Bogdanova N; Dörk T; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Shu XO; Lu W; Gao YT; Zhang B; Couch FJ; Toland AE; ; Yannoukakos D; Sangrajrang S; McKay J; Wang X; Olson JE; Vachon C; Purrington K; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Devilee P; Tollenaar RA; Seynaeve C; Czene K; Eriksson M; Humphreys K; Darabi H; Ahmed S; Shah M; Pharoah PD; Hall P; Giles GG; Benítez J; Dunning AM; Chenevix-Trench G; Easton DF
    Hum Mol Genet; 2014 Nov; 23(22):6096-111. PubMed ID: 24943594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk.
    Fletcher O; Johnson N; Palles C; dos Santos Silva I; McCormack V; Whittaker J; Ashworth A; Peto J
    J Natl Cancer Inst; 2006 Jul; 98(14):1014-8. PubMed ID: 16849685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKAP9 is a genetic modifier of congenital long-QT syndrome type 1.
    de Villiers CP; van der Merwe L; Crotti L; Goosen A; George AL; Schwartz PJ; Brink PA; Moolman-Smook JC; Corfield VA
    Circ Cardiovasc Genet; 2014 Oct; 7(5):599-606. PubMed ID: 25087618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans.
    Logue MW; Schu M; Vardarajan BN; Farrell J; Bennett DA; Buxbaum JD; Byrd GS; Ertekin-Taner N; Evans D; Foroud T; Goate A; Graff-Radford NR; Kamboh MI; Kukull WA; Manly JJ; ;
    Alzheimers Dement; 2014 Nov; 10(6):609-618.e11. PubMed ID: 25172201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
    Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
    J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.
    Fletcher O; Johnson N; Orr N; Hosking FJ; Gibson LJ; Walker K; Zelenika D; Gut I; Heath S; Palles C; Coupland B; Broderick P; Schoemaker M; Jones M; Williamson J; Chilcott-Burns S; Tomczyk K; Simpson G; Jacobs KB; Chanock SJ; Hunter DJ; Tomlinson IP; Swerdlow A; Ashworth A; Ross G; dos Santos Silva I; Lathrop M; Houlston RS; Peto J
    J Natl Cancer Inst; 2011 Mar; 103(5):425-35. PubMed ID: 21263130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.
    Yu KD; Di GH; Li WF; Rao NY; Fan L; Yuan WT; Hu Z; Wu J; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 May; 121(1):157-67. PubMed ID: 19728081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic predisposition of six well-defined polymorphisms in HMGB1/RAGE pathway to breast cancer in a large Han Chinese population.
    Yue L; Zhang Q; He L; Zhang M; Dong J; Zhao D; Ma H; Pan H; Zheng L
    J Cell Mol Med; 2016 Oct; 20(10):1966-73. PubMed ID: 27241711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged Lu J; Wei Q; Bondy ML; Brewster AM; Bevers TB; Yu TK; Buchholz TA; Meric-Bernstam F; Hunt KK; Singletary SE; Wang LE
    Breast Cancer Res Treat; 2008 Jul; 110(2):357-66. PubMed ID: 17851762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP3A variation, premenopausal estrone levels, and breast cancer risk.
    Johnson N; Walker K; Gibson LJ; Orr N; Folkerd E; Haynes B; Palles C; Coupland B; Schoemaker M; Jones M; Broderick P; Sawyer E; Kerin M; Tomlinson IP; Zvelebil M; Chilcott-Burns S; Tomczyk K; Simpson G; Williamson J; Hillier SG; Ross G; Houlston RS; Swerdlow A; Ashworth A; Dowsett M; Peto J; Dos Santos Silva I; Fletcher O
    J Natl Cancer Inst; 2012 May; 104(9):657-69. PubMed ID: 22472546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].
    Wang ML; Xu YX; Qian J; Wang FH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Feb; 47(2):124-8. PubMed ID: 23719102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between LSP1 polymorphisms and the susceptibility to breast cancer.
    Chen H; Qi X; Qiu P; Zhao J
    Int J Clin Exp Pathol; 2015; 8(5):5798-802. PubMed ID: 26191300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility.
    Suárez-Rama JJ; Arrojo M; Sobrino B; Amigo J; Brenlla J; Agra S; Paz E; Brión M; Carracedo Á; Páramo M; Costas J
    J Psychiatr Res; 2015; 66-67():38-44. PubMed ID: 25943950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
    Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
    BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variant rs16430 6bp > 0bp at the microRNA-binding site in TYMS and risk of sporadic breast cancer risk in non-Hispanic white women aged ≤ 55 years.
    Guan X; Liu H; Ju J; Li Y; Li P; Wang LE; Brewster AM; Buchholz TA; Arun BK; Wei Q; Liu Z
    Mol Carcinog; 2015 Apr; 54(4):281-90. PubMed ID: 24166930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synergistic effect between adult weight changes and CYP24A1 polymorphisms is associated with pre- and postmenopausal breast cancer risk.
    Cao S; Wei F; Zhou J; Zhu Z; Li W; Wu M
    Breast Cancer Res Treat; 2020 Jan; 179(2):499-509. PubMed ID: 31696340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-nucleotide polymorphisms in DNA bypass polymerase genes and association with breast cancer and breast cancer subtypes among African Americans and Whites.
    Family L; Bensen JT; Troester MA; Wu MC; Anders CK; Olshan AF
    Breast Cancer Res Treat; 2015 Jan; 149(1):181-90. PubMed ID: 25417172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.